Back to All Events

Harnessing AI in Clinical Trials: Guardrails, Governance, and Real-World Readiness

Artificial Intelligence (AI) is no longer a futuristic concept in clinical trials, it’s an emerging reality with real-world impact across design, recruitment, operations, and data analysis. This session presents insights from a multi-stakeholder working group exploring how AI is being applied in practice, what responsible use looks like, and what collective standards are needed to ensure adoption accelerates rather than fragments progress. Through interactive discussion and scenario-based exploration, participants will examine proposed practical frameworks for AI governance, definitions of responsible use, and baseline metrics for measuring AI’s effectiveness. The session will also outline regulatory engagement strategies and explore key global differences in AI oversight. Attendees will leave with tools to guide internal conversations, assess vendor claims, and contribute to shared industry alignment on AI in trials.

CEU: 1.00 ACRP

Speaker:

Earlier Event: April 25
Protecting Vulnerable Patients in Oncology Trials Through Optimized Informed Consent
Later Event: April 25
Risk-Averse or Recklessly Traditional?: Considering the Cognitive Dissonance of Clinical Research